Inventor · disambiguated record
Joel Kaye
Also filed as: KAYE JOEL · KAYE JOEL FLAXMAN
7 granted patents·36 pending applications·79 citations·filing 2010–2025
82Inventor score
Top patents by PatentIndex Score
43 records- 0193US8598203B2Treatment of Crohn's disease with laquinimodTARCIC NORA·Filed 2010·Granted Dec 3, 2013·68 cites·24 claims
- 0288US11478465B2Compounds for treatment of eye diseases associated with excessive vascularisationACTIVE BIOTECH AB·Filed 2021·Granted Oct 25, 2022·4 cites·15 claims
- 0385US2025134881A1Treatment of ocular inflammatory diseases using laquinimodACTIVE BIOTECH AB·Filed 2024·Application pending·0 cites
- 0481US8889627B2Treatment of multiple sclerosis with combination of laquinimod and fingolimodTEVA PHARMA·Filed 2012·Granted Nov 18, 2014·5 cites·20 claims
- 0573US2021386731A1Treatment of ocular inflammatory diseases using laquinimodACTIVE BIOTECH AB·Filed 2021·Application pending·0 cites
- 0668US9161935B2Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapyTARCIC NORA·Filed 2013·Granted Oct 20, 2015·1 cites·21 claims
- 0767US12208091B2Compounds for treatment of eye diseases associated with excessive vascularisationACTIVE BIOTECH AB·Filed 2022·Granted Jan 28, 2025·0 cites·15 claims
- 0863US11654140B2Treatment of ocular inflammatory diseases using laquinimodACTIVE BIOTECH AB·Filed 2017·Granted May 23, 2023·0 cites·25 claims
- 0960US8501766B2Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexateKAYE JOEL·Filed 2011·Granted Aug 6, 2013·1 cites·10 claims
- 1060US2018050031A1Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl FumarateTEVA PHARMA·Filed 2017·Application pending·0 cites
- 1160US2014200243A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2014·Application pending·0 cites
- 1260US2018000812A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2017·Application pending·0 cites
- 1359US2017266180A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2017·Application pending·0 cites
- 1459US2014057883A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2013·Application pending·0 cites
- 1558US2016296512A1Treatment of crohn's disease with laquinimodTEVA PHARMA·Filed 2016·Application pending·0 cites
- 1658US2017136003A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2017·Application pending·0 cites
- 1758US2013259856A1Treatment of multiple sclerosis with combination of laquinimod and dimethyl fumarateKAYE JOEL FLAXMAN·Filed 2013·Application pending·0 cites
- 1858US2017319570A1Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl FumarateKAYE JOEL FLAXMAN·Filed 2017·Application pending·0 cites
- 1957US2017020857A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2016·Application pending·0 cites
- 2057US2015037263A1Treatment of multiple sclerosis with combination of laquinimod and fingolimodHALLAK HUSSEIN·Filed 2014·Application pending·0 cites
- 2157US2017224675A1Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl FumarateKAYE JOEL FLAXMAN·Filed 2017·Application pending·0 cites
- 2254US2025295446A1Neuronavigation-Compatible Inner Cannula for Percutaneous Radiofrequency LesioningUNIV CINCINNATI·Filed 2025·Application pending·0 cites
- 2354US2023018980A1Bisfluoroalkyl-1,4-benzodiazepinone compounds for treating desmoid tumorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2453US2017333420A1Treatment of ocular inflammatory diseases using laquinimodKAYE JOEL·Filed 2017·Application pending·0 cites
- 2553US2017333418A1Treatment of multiple sclerosis with combination of laquinimod and fingolimodHALLAK HUSSEIN·Filed 2017·Application pending·0 cites
- 2653US2016000774A1Treatment of multiple sclerosis with combination of laquinimod and dimethyl fumarateKAYE JOEL FLAXMAN·Filed 2015·Application pending·0 cites
- 2753US2013324574A1Treatment of ocular inflammatory diseases using laquinimodKAYE JOEL·Filed 2013·Application pending·0 cites
- 2852US2017231971A1Treatment of ocular inflammatory diseases using laquinimodKAYE JOEL·Filed 2017·Application pending·0 cites
- 2951US2022339162A1Bisfluoroalkyl-1,4-benzodiazepinone compounds for treating desmoid tumorsAYALA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3051US2024299411A1Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treating cancerAYALA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3151US2015119420A1Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl FumarateKAYE JOEL FLAXMAN·Filed 2015·Application pending·0 cites
- 3251US2016279118A1Treatment of multiple sclerosis with combination of laquinimod and fingolimodTEVA PHARMA·Filed 2016·Application pending·0 cites
- 3350US2015094332A1Laquinimod Combination Therapy For Treatment Of Multiple SclerosisKNAPPERTZ VOLKER·Filed 2014·Application pending·0 cites
- 3449US2017290822A1Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapyTARCIC NORA·Filed 2017·Application pending·0 cites
- 3547US2023381196A1Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treating adenoid cystic carcinomaAYALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3645US2017304253A1Laquinimod Combination Therapy For Treatment Of Multiple SclerosisKNAPPERTZ VOLKER·Filed 2017·Application pending·0 cites
- 3744US2015359788A1Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapyTARCIC NORA·Filed 2015·Application pending·0 cites
- 3843US2016303116A1Treatment of multiple sclerosis with a 1,2,4-triazolo [1,5a] pyridine derivativeCEPHALON INC·Filed 2014·Application pending·0 cites
- 3942US2016271094A1Laquinimod Combination Therapy For Treatment Of Multiple SclerosisKNAPPERTZ VOLKER·Filed 2016·Application pending·0 cites
- 4041US2014017226A1Treatment of multiple sclerosis with combination of laquinimod and fampridineKAYE JOEL·Filed 2013·Application pending·0 cites
- 4140US2014275215A1Anti-clusterin monotherapy for cancer treatmentTESSLER SHOSHI·Filed 2014·Application pending·0 cites
- 4236US2018036302A1Treatment of multiple sclerosis with combination of laquinimod and a statinPIRYATINSKY VICTOR·Filed 2015·Application pending·0 cites
- 4335US2016235735A1Treatment of multiple sclerosis with combination of laquinimod and fampridineKAYE JOEL·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →